Purpose: To determine the effect of three calmodulin antagonists (A-7, W-7 and W-13) 
INTRODUCTION
Breast cancer cells have been reported to contain more than one immunophenotype subpopulations that have different invasive properties and roles in tumorigenicity [1, 2] . They were distinguished according to the expression level of two glycoproteins on the surface of the cells, CD44 and CD24, markers of breast cancer cell phenotype since CD44 binds E-selectin and CD24 is known to be attached to P-selectin [3, 4] . Cells with high levels of CD44 and low level of CD24 (CD44 + CD24-) were identified as cancer stem cells that have the ability to self-renew and differentiate. In spite of the arguable clinical significance of CD44+CD24-, they have been associated with distant metastasis and unfortunate survival [5] .
CD44 is a ubiquitous multi-structural and multifunctional cell surface glycoprotein involved in adhesive cell-cell and cell-matrix interactions, and cell migration and cell homing.
A previous study reported that by ectopically overexpressing a splice variant of CD44, it was enough for a non-metastatic rat glioma cell line to attain metastatic properties [6] . The variant isoforms of CD44 have showed antiproliferative and apoptotic effect [7, 8] .
While CD44 is associated with stem cell-like cancer cells, CD24 is correlated with either luminal or basal breast cancer cells [9] . In the presence of high proportions of CD24+, the luminal cells are likely to exist whereas the basal cells are expressed at higher percentages of CD24-.
Several compounds have been tested for inhibiting CD44 such as the calcium-modulated protein (calmodulin) antagonists (chlorpromazine, trifluoperazine, W-7) and the calcium blocker verapamil [10] . However, the study did not test the effect of these compounds on breast cancer stem cells. It is not known, however, whether targeting CD44 can alter the fate of cancer stem cells themselves. In this study, the effect of the calmodulin antagonists (N-(10-Aminodecyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (A-7), N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) and N-(4-Aminobutyl)-5-chloro-2-naphthalenesulfonamide hydrochloride (W-13)) on MDA-MB-231 and MDA-MB-468 breast cancer cell lines was investigated.
EXPERIMENTAL Materials and cell lines
Monoclonal antibodies against human CD44 (FITC; cat. #555478) and CD24 (PE; cat. #555428) were obtained from BD Biosciences (San Diego, CA, USA). The breast cancer cell lines (MDA-MB-231 and MDA-MB-468) were obtained from American Type Tissue Culture Collection (Manassas, VA, USA).
Flow cytometric analysis of cancer stem cells subjected to A-7, W-7 and W-13
Cells were cultured and incubated in different concentrations of A-7, W-7 and W-13 for 24 hours as described elsewhere [11] . Cells were washed once with phosphate-buffered saline (PBS) and then harvested with 0.05 % trypsin/0.025 % ethylenediaminetetraacetic acid (EDTA). Detached cells were washed with PBS containing 1 % fetal calf serum and 1 % penicillin/streptomycin (washing buffer), and resuspended in the wash buffer (106 cells/100 μL). Combinations of fluorochrome-conjugated monoclonal antibodies against human CD44 and CD24 or their respective isotype controls were added to the cell suspension at concentrations recommended by the manufacturer and incubated at 4 °C in the dark for 30 to 40 min. The labeled cells were washed in the wash buffer, and then were analyzed using the flow cytometry.
Matrigel invasion assay
The invasion assay was performed as recommended by the manufacturer of the invasion assay kit (#ECM554; Chemicon International, Temecula, CA, USA). Briefly, cells were serum starved and incubated for 24 h. The 50,000 cells were placed on the top insert with matrigel. Serum-free media supplemented with several concentrations of W-13 or media with 10 % serum was placed in the bottom well. After 24 h, the number of cells that invaded through the matrigel were calculated using fluorometric assay. For each cell line, the fluorometric reading from bottom wells with the serum-free media was defined as one unit to determine relative change in invasion in the presence of 10 % serum. Each experiment contained one or two wells without serum and two wells with serum for each cell line. The experiment was repeated twice for MDA-MB-231 and MDA-MB-468.
Statistical analysis
Data were represented as mean ± standard deviation ( ). Statistical analysis was carried out with one-way analysis of variance (ANOVA) and difference between groups was considered significant at p < 0.05.
RESULTS

Effect of A-7, W-7 and W-13 on CD44/CD24 immunophenotypic subpopulations of MDA-MB-231 and MDA-MB-468
As shown in Figure 1 , all calmodulin antagonists (A-7, W-7 and W-13) caused alterations in the subpopulation of the phonotypic CD44 + CD24-of MDA-MB-231 cells. At lower concentrations (20 µM), the percentages of the CD44 + CD24-subpopulation were similar when subjected into the calmodulin antagonists of A-7, W-7 and W-13 as they were 75.36 ± 2.34, 65.44 ± 7.5 and 61.47 ± 4.9, respectively.
However, when the concentrations of the antagonists were increased, there were some discrepancies in the percentages of the subpopulation of CD44+CD24-cells. As displayed in Figure 1a , the antagonist, A-7, caused reduction in the percentages of the expressed CD44+CD24-from 75.36 ± 2.34 to 38.63 ± 5.7 when the concentration of A-7 was enhanced from 20 to 60 µM but the percentages of CD44+CD24-increased to 79.76 ± 3.4 and 77.97 ± 5.6 when the concentration was increased into 80 and 100 µM, respectively.
On the other hand, both of W-7 and W-13 have caused reduction in the percentages of the expressed CD44+CD24-cells as their concentration increased from 20 to 100 µM (Figures 1b and 1c) . The antagonist, W-13, was more potent than W-7 as the percentages of CD44+CD24-cells were considerably reduced at different concentrations (40 -100 µM) compared to W-7. At 100 µM, W-7 and W-13 reduced the proportion of CD44 + CD24-to 30.27 and 0.44, respectively.
Furthermore, the effect of W-7 and W-13 on CD44/CD24 immunophenotypic subpopulations of MDA-MB-468 cells was determined. It was observed that the expression of CD44+CD24-when subjected to different concentrations of W-7 (20 -100 µM) was zero and most of the expressed cells were the luminal CD44+CD24+ with a percentage of 99.54 ± 0.12 whereas the percentages of the CD44-CD24+ were in the range of 0.37-0.66. In contrast, the MDA-MB-468 cells administered different concentrations of W-13 revealed that the percentages of CD44+CD24-did not significantly differ as they were in the range of 0.1-0.27 (Figure 2) . Interestingly, as the concentration of W-13 increased, the percentages of the subpopulations of CD44+CD24+ decreased whereas the percentages of the subpopulations of CD44-CD24+ increased. 
DISCUSSION
Calmodulin antagonists have antitumor activities against various cancers which could be explained by the role of calmodulin in raising the rate of cell growth and degree of tumor malignancy [12] .
For example, W-7 has antiproliferative effect against skin cancer [13] and has the potential to suppress the expression of the MTS1 and NM23 genes in highly metastatic murine melanoma cells [14] . They demonstrated that the  cancer cells with the immunophenotype,  CD44+CD24-, were able to initiate tumor  whereas  other  phenotype  populations,  CD44+CD24+, CD44-CD24+, were nontumorigenic cancer cells. In this study, calmodulin antagonists, A-7, W-7 and W-13, were subjected MDA-MB-231 breast cancer cells in order to look for their effect on the proportions of the immunophenotype subpopulations of the breast cancer cells. Based on flow cytometry analysis, it has been found that W-13 has the greatest inhibition effect on the expression of CD44+CD24-. In particular, 80 µM of W-13 was sufficient to reduce the proportion of CD44+CD24-from 61.47 ± 4.9 to 0.64± 0.05 %. Furthermore, increasing the concentration of W-13 lowered the proportion of the phenotype CD44+CD24+ and enhanced the proportion of CD44-CD24+ in MDA-MB-468 cells which resulted in reducing the invasive properties of the cells. Meyer et al [18] found that CD44+CD24+ cause local invasion by stimulating the expression of CD44+CD24-while CD44-CD24+ does not have effect on the metastatic properties of breast cancer cells.
CONCLUSION
Among the selected calmodulin antagonists, W-13 had the greatest antitumor effect in both MDA-MB-231 and MDA-MB-468 cells. As the concentration of W-13 increased, the proportion of CD44+CD24-in MDA-MB-231 significantly diminished whereas the proportion of CD44+CD24+ in MDA-MB-468 cells reduced. These alterations in the proportion of the subpopulations of CD44/CD24 immunophenotypes are consistent with the suppression of the invasive properties of MDA-MB-231 and MDA-MB-468 cells.
